Stanislas Ropert
Impact in
- Geriatrics and Gerontology top 2%
- Frailty in Older Adults
- Oncology top 2%
- Cancer Risks and Factors
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 39
- Cancer Treatment and Pharmacology 15
- Colorectal Cancer Treatments and Studies 13
- HER2/EGFR in Cancer Research 5
- Lung Cancer Research Studies 5
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Olivier Mir (47 shared papers)François Goldwasser (39 shared papers)Romain Coriat (27 shared papers)Benoı̂t Blanchet (15 shared papers)Pascaline Boudou‐Rouquette (15 shared papers)Stanislas Chaussade (7 shared papers)Bertrand Billemont (14 shared papers)Jean-Philippe Durand (14 shared papers)
- Journals
- Investigational New Drugs (11 papers)Journal of Clinical Oncology (9 papers)Annals of Oncology (5 papers)Anti-Cancer Drugs (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Stanislas Ropert
67 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 108
- Geriatrics and Gerontology 178
- Oncology 1.1k
- Hepatology 287
- Pulmonary and Respiratory Medicine 757
- Cancer Research 296
Countries citing papers authored by Stanislas Ropert
This map shows the geographic impact of Stanislas Ropert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislas Ropert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislas Ropert more than expected).
Fields of papers citing papers by Stanislas Ropert
This network shows the impact of papers produced by Stanislas Ropert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislas Ropert. The network helps show where Stanislas Ropert may publish in the future.
Co-authors
The 25 scholars most cited alongside Stanislas Ropert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 242 | |
| 2 | 2020 | 215 | |
| 3 | 2013 | 186 | |
| 4 | 2012 | 170 | |
| 5 | 2008 | 121 | |
| 6 | 2009 | 104 | |
| 7 | 2008 | 95 | |
| 8 | 2011 | 86 | |
| 9 | 2012 | 86 | |
| 10 | 2011 | 83 | |
| 11 | 2007 | 79 | |
| 12 | 2011 | 67 | |
| 13 | 2011 | 60 | |
| 14 | 2009 | 57 | |
| 15 | 2011 | 56 | |
| 16 | 2011 | 55 | |
| 17 | Emerging therapeutic options for breast cancer chemotherapy during pregnancy | 2008 | 52 |
| 18 | 2010 | 47 | |
| 19 | 2010 | 43 | |
| 20 | 2011 | 40 |
About Stanislas Ropert
Stanislas Ropert is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Hepatology and Surgery, having authored 67 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Colorectal Cancer Treatments and Studies (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Lung Cancer Treatments and Mutations (8 papers), HER2/EGFR in Cancer Research (5 papers), Lung Cancer Research Studies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Geriatrics and Gerontology (178 citations), Oncology (1.1k citations), Hepatology (287 citations), Pulmonary and Respiratory Medicine (757 citations) and Cancer Research (296 citations). Stanislas Ropert has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Olivier Mir, François Goldwasser, Romain Coriat, Benoı̂t Blanchet, Pascaline Boudou‐Rouquette, Stanislas Chaussade, Bertrand Billemont, Jean-Philippe Durand, Paul Berveiller and François Goffinet. Their work appears in journals such as Investigational New Drugs, Journal of Clinical Oncology, Annals of Oncology, Anti-Cancer Drugs and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.